$11.70
-0.85-6.75%
Last update: 1:03 PM
15 minutes delayed
Novavax
NVAXNASDAQ
Novavax (NASDAQ:NVAX) Stock, Earnings Estimates, EPS, And Revenue
Novavax reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 10
EPS
$-1.050
Quarterly Revenue
$93.9M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$656.7M
Analyze the earnings history of Novavax using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NVAX | Novavax | $0.58 | — | — | — | $424.43M | — | — | — | 08/06/2024 | Get Alert |
| NVAX | Novavax | -$3.41 | -$1.06 | -$1.05 | 0.94% | $80.95M | $101.16M | $93.86M | -7.22% | 05/10/2024 | Get Alert |
| NVAX | Novavax | -$2.28 | -$0.45 | -$1.47 | -226.67% | $357.40M | $321.65M | $291.34M | -9.42% | 02/28/2024 | Get Alert |
| NVAX | Novavax | -$2.15 | -$1.83 | -$1.26 | 31.15% | $734.58M | $158.54M | $186.99M | 17.94% | 11/09/2023 | Get Alert |
| NVAX | Novavax | -$6.53 | -$1.24 | $0.58 | 146.77% | $185.93M | $257.62M | $424.43M | 64.75% | 08/08/2023 | Get Alert |
| NVAX | Novavax | $2.56 | -$3.46 | -$3.41 | 1.45% | $703.97M | $87.61M | $80.95M | -7.60% | 05/09/2023 | Get Alert |
| NVAX | Novavax | -$11.18 | -$0.92 | -$2.28 | -147.83% | $222.20M | $383.14M | $357.40M | -6.72% | 02/28/2023 | Get Alert |
| NVAX | Novavax | -$4.31 | $1.57 | -$2.15 | -236.94% | $178.84M | $586.25M | $734.58M | 25.30% | 11/08/2022 | Get Alert |
| NVAX | Novavax | -$4.75 | $6.36 | -$6.53 | -202.67% | $298.02M | — | $185.93M | — | 08/08/2022 | Get Alert |
| NVAX | Novavax | -$3.05 | $2.69 | $2.56 | -4.83% | $447.23M | $845.20M | $703.97M | -16.71% | 05/09/2022 | Get Alert |
| NVAX | Novavax | -$2.70 | -$1.80 | -$11.18 | -521.11% | $276.66M | $331.79M | $222.20M | -33.03% | 02/28/2022 | Get Alert |
| NVAX | Novavax | -$3.21 | -$3.91 | -$4.31 | -10.23% | $157.02M | $334.62M | $178.84M | -46.55% | 11/04/2021 | Get Alert |
| NVAX | Novavax | -$0.30 | -$3.63 | -$4.75 | -30.85% | $35.54M | $387.87M | $298.02M | -23.17% | 08/05/2021 | Get Alert |
| NVAX | Novavax | -$0.58 | -$3.60 | -$3.05 | 15.28% | $3.38M | $233.90M | $447.23M | 91.21% | 05/10/2021 | Get Alert |
| NVAX | Novavax | -$1.13 | -$1.49 | -$2.70 | -81.21% | $8.82M | $304.88M | $276.66M | -9.26% | 03/01/2021 | Get Alert |
| NVAX | Novavax | -$0.74 | $1.73 | -$3.21 | -285.55% | $2.51M | $230.56M | $157.02M | -31.89% | 11/09/2020 | Get Alert |
| NVAX | Novavax | -$1.69 | -$0.42 | -$0.30 | 28.57% | $3.36M | $39.58M | $35.54M | -10.21% | 08/10/2020 | Get Alert |
| NVAX | Novavax | -$2.20 | -$0.78 | -$0.58 | 25.64% | $3.98M | $1.74M | $3.38M | 94.08% | 05/11/2020 | Get Alert |
| NVAX | Novavax | -$2.60 | -$1.06 | -$1.13 | -6.60% | $6.13M | — | $8.82M | — | 03/11/2020 | Get Alert |
| NVAX | Novavax | -$2.40 | -$0.98 | -$0.74 | 24.49% | $7.74M | $2.53M | $2.51M | -0.91% | 11/07/2019 | Get Alert |
| NVAX | Novavax | -$2.40 | -$1.61 | -$1.69 | -4.97% | $10.77M | $3.06M | $3.36M | 9.71% | 08/07/2019 | Get Alert |
Novavax (NVAX) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-10 | $-1.05 | $-1.06 | 0.94 % |
| Dec 2023 | 2024-02-28 | $-1.47 | $-0.45 | -226.7 % |
| Sep 2023 | 2023-11-09 | $-1.26 | $-1.83 | 31.1 % |
| Jun 2023 | 2023-08-08 | $0.58 | $-1.24 | 146.8 % |
Novavax (NVAX) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-10 | $93.86M | $101.16M | -7.22 % |
| Dec 2023 | 2024-02-28 | $291.34M | $321.65M | -9.42 % |
| Sep 2023 | 2023-11-09 | $186.99M | $158.54M | 17.9 % |
| Jun 2023 | 2023-08-08 | $424.43M | $257.62M | 64.8 % |
FAQ
When is Novavax (NASDAQ:NVAX) reporting earnings?
Novavax (NVAX) is scheduled to report earnings on August 6, 2024. The last reported earnings were for reported on May 10, 2024 for Q1.
What were the latest earnings per share (EPS) for Novavax (NASDAQ:NVAX)?
The Actual EPS was $-1.05, which beat the estimate of $-1.06.
What were Novavax’s (NASDAQ:NVAX) revenues?
The Actual Revenue was $93.9M, which missed the estimate of $101.2M.
Browse earnings estimates, EPS, and revenue on all stocks.